Thermo Fisher Scientific
TMO
817 hedge funds and large institutions have $32.8B invested in Thermo Fisher Scientific in 2013 Q3 according to their latest regulatory filings, with 76 funds opening new positions, 252 increasing their positions, 370 reducing their positions, and 55 closing their positions.
38% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 55
9% more capital invested
Capital invested by funds: $30.1B → $32.8B (+$2.62B)
2% more funds holding
Funds holding: 802 → 817 (+15)
0.14% less ownership
Funds ownership: 98.94% → 98.8% (-0.14%)
8% less funds holding in top 10
Funds holding in top 10: 72 → 66 (-6)
32% less repeat investments, than reductions
Existing positions increased: 252 | Existing positions reduced: 370
39% less call options, than puts
Call options by funds: $164M | Put options by funds: $267M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$293M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$195M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$170M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$128M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$234M |
| 2 |
LCG
Luxor Capital Group
New York
|
-$171M |
| 3 |
TP
Third Point
New York
|
-$85.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$85.6M |
| 5 |
Axa
Paris,
France
|
-$73.5M |
TMO Hedge Fund Activity: Q3 2013 in Review
817 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2013, worth a combined $32.8B — up 8.7% from $30.1B a quarter earlier.
Buyers outnumbered sellers: 76 funds opened new TMO positions and 55 closed out — a net gain of 21 holders — while 252 added to existing stakes and 370 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $293M. The largest seller was Lone Pine Capital, exiting entirely with an estimated $234M sold.
- 817 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2013, up from 802 in Q2 2013.
- Funds reported $32.8B of Thermo Fisher Scientific stock for Q3 2013, up 8.7% quarter-over-quarter.
- 76 funds opened new Thermo Fisher Scientific positions in Q3 2013 and 55 closed out, a net change of +21 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2013 was Fidelity Investments, an estimated $293M added.
- The largest Thermo Fisher Scientific seller in Q3 2013 was Lone Pine Capital, an estimated $234M sold.
Based on aggregated 13F filings for Q3 2013.